{"Title": ["Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/13/2020", "Catalyst Pharmaceuticals Inc (CPRX) Q1 2020 Earnings Call Transcript", "Healthcare Pro Steven Boyd Is Gobbling Up These 3 Stocks", "Is Catalyst Pharmaceuticals a Buy?", "30 Top Stocks and Funds to Beat the COVID-19 Bear Market", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 4/2/2020", "5 Absurdly Cheap Biotech Stocks That Could Make You Filthy Rich", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 3/18/2020", "Validea Joel Greenblatt Strategy Daily Upgrade Report - 5/13/2020", "These 14 Stocks Are Stupid Cheap", "Can Catalyst Pharmaceuticals Stock Rebound in 2020?", "Why Catalyst Pharmaceuticals Stock Jumped Today", "Is Catalyst Pharmaceuticals Stock Safe to Own?", "Catalyst Pharmaceuticals Inc (CPRX) Q3 2019 Earnings Call Transcript", "Why Catalyst Pharmaceuticals Stock Is Falling Today", "3 \u2018Strong Buy\u2019 Stocks to Buy on Weakness", "Catalyst Pharmaceuticals Inc (CPRX) Q4 2019 Earnings Call Transcript", "Catalyst Pharma: Are the Risks Worth the Potential Rewards?", "Friday 10/4 Insider Buying Report: WMS, CPRX", "3 Top Small-Cap Stocks to Buy in October", "Catalyst Pharmaceuticals: Nothing Has Changed", "Why Catalyst Pharmaceuticals Stock Is Tumbling Today", "3 Top Biotech Stocks to Buy in September", "Health Care Sector Update for 09/13/2019: RTTR, FCSC, CPRX, JNJ, PFE, MRK, ABT, AMGN", "Catalyst Pharmaceuticals: Buy the Dip?", "Health Care Sector Update for 09/12/2019: VXRT,PDLI,ACB,CPRX", "Health Care Sector Update for 09/12/2019: ACB,PDLI,CPRX", "Why Catalyst Pharmaceuticals Stock Is Sinking Today", "Catalyst Pharmaceuticals Inc (CPRX) Q2 2019 Earnings Call Transcript", "Why Catalyst Pharmaceuticals Stock Broke Down Today", "2 Small-Cap Stocks That Could Make You Rich", "2 Top Stocks to Buy in August", "5 Top Losers In Healthcare Sector (TOCA, ADVM, CPRX\u2026)", "Health Care Sector Update for 09/12/2019: VXRT,PDLI,ACB,CPRX", "Why Catalyst Pharmaceuticals Briefly Spiked Today", "Catalyst Pharmaceuticals Inc (CPRX) Q1 2019 Earnings Call Transcript", "Why Catalyst Pharmaceuticals Stock Is Jumping Today", "Health Care Sector Update for 05/07/2019: PINC,CPRX,HSIC,REGN,SNY", "Health Care Sector Update for 05/07/2019: CPRX,HSIC,REGN,SNY", "Mid-Day Market Update: Nautilus Falls On Downbeat Q1 Results; Cohu Shares Surge", "Are These 2 Beaten-Down Biotech Stocks Worth the Risk?", "7 Top Gainers In Healthcare Sector (TLSA, SWAV, CPRX...)", "Why Catalyst Pharmaceuticals, Inc. Soared in March", "3 Top Biotech Stocks to Buy Right Now", "2 High-Growth Stocks I'd Buy Right Now", "Why Catalyst Pharmaceuticals Stock Is Popping Today", "Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse", "Why Catalyst Pharmaceuticals Is Getting Crushed Today", "Health Care Sector Update for 05/07/2019: CPRX, GWPH, MNK, JNJ, PFE, ABT, MRK, AMGN", "U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug", "Catalyst defends $375,000 drug price after Bernie Sanders rebuke", "Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke", "Catalyst defends drug price after Bernie Sanders' rebuke", "U.S. Senator Sanders asks why drug, once free, now costs $375k", "Catalyst Pharmaceuticals Inc (CPRX) Q4 2018 Earnings Conference Call Transcript", "After-Hours Earnings Report for March 18, 2019 : HQY, SYNH, AKBA, XELA, TACO, CPRX, CHMI, FENG, MCF, ICAD", "U.S. Senator Sanders urges FDA to allow older versions of $375K drug", "U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug", "Why Catalyst Pharmaceuticals Stock Is Sinking Today", "Health Care Sector Update for 11/28/2018: IPCI,CPRX,GWPH", "Health Care Sector Update for 11/28/2018: AQB,IPCI,CPRX,GWPH", "U.S. Senator Sanders to ask why drug, once free, now costs $375k", "Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update", "4 Strong Buy Biotech Stocks With Upcoming FDA Decisions", "Catalyst Pharmaceuticals (CPRX) Catches Eye: Stock Jumps 6.3%", "Catalyst (CPRX) Up 16% Since Last Earnings Report: Can It Continue?", "Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q2", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Catalyst's Fridapse Gets Priority Review by FDA, Shares Up", "Health Care Sector Update for 11/28/2018: THC,IPCI,CPRX,GWPH", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Catalyst Enrolls First Patient in Phase III Firdapse Study", "Catalyst Pharmaceuticals (CPRX) Down 7.4% Since Earnings Report: Can It Rebound?", "Catalyst (CPRX) Up on New Drug Application for Firdapse", "Health Care Sector Update for 03/29/2018: CPRX,CGEN,BIOC,PSDV,HRTX", "Catalyst (CPRX) Posts In-Line Q4 Loss, Pipeline in Progress", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Catalyst (CPRX) Posts In-Line Q1 Loss, Pipeline Progresses", "What Drives Catalyst Pharmaceuticals Above 250% This Year?", "3 Drug Stocks That Soared This Week: Are They Buys?", "Catalyst (CPRX) Reports Positive Phase III Data on Firdapse", "Catalyst Initiates Phase II Study for Pipeline Drug Firdapse", "Catalyst (CPRX) Posts Narrower-Than-Expected Loss in Q3", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Catalyst (CPRX) Focused on Two Lead Pipeline Candidates", "Catalyst Gets Positive FDA Advise on Firdapse NDA Refiling", "Catalyst (CPRX) Focused on Development of Pipeline Candidates", "Catalyst (CPRX) Posts Narrower than Expected Loss in Q2", "What's in Store for Catalyst (CPRX) This Earnings Season?", "Mid-Morning Market Update: Markets Edge Higher; Delta Air Lines Profit Misses Expectations", "Catalyst (CPRX) Shows Strength: Stock Adds 9.6% in Session", "Why is Catalyst Pharmaceuticals' Stock Up 160% this Year?", "Mid-Morning Market Update: Markets Open Lower; Lennar Tops Q2 Expectations", "Thursday 9/7 Insider Buying Report: TITN, CPRX", "Catalyst (CPRX) Focused on Development of Pipeline Candidates", "Catalyst (CPRX) Posts Narrower than Expected Loss in Q2", "What's in Store for Catalyst (CPRX) This Earnings Season?", "What's in Store for Catalyst (CPRX) Stock in Q1 Earnings?", "Catalyst (CPRX) Up 16.6% Since Earnings Report: Can It Continue?", "Catalyst Pharmaceuticals (CPRX) Jumps: Stock Gains 18.2%", "Catalyst Pharma (CPRX) Focused on U.S. Approval for Firdapse", "Why Is Catalyst Pharmaceuticals (CPRX) Up 25.5% Since the Last Earnings Report?", "Midday Update: Countdown to FOMC; Stocks Trade Higher on Uptick in Oil, Banking Shares", "Mid-Day Market Update: FTD Companies Drops After Q4 Results; Cesca Therapeutics Shares Surge", "Close Update: Stocks Rally as Fed Rate Hike Tempered by \"Confidence in Robustness of Economy\"", "Health Care Sector Update for 03/15/2017: VRX,CPRX,CXRX", "Mid-Afternoon Market Update: Crude Oil Up Over 2%; FTD Companies Shares Plunge", "Health Care Sector Update for 03/15/2017: KOOL,CPRX,CXRX", "Health Care Sector Update for 03/14/2017: BIOC", "Catalyst (CPRX) Reports Narrower-than-Expected Loss in Q4", "Alexion (ALXN) Offers Long-Term Phase III Data on Kanuma", "Catalyst (CPRX) Reports Narrower-than-Expected Loss in Q3", "Catalyst Pharma (CPRX) Q3 Earnings: Will Stock Surprise?", "Health Care Sector Update for 10/31/2016: CPRX, TMH, ZBH, BX", "Midday Update: Oil Fuels Triple-Digit Gain in Dow", "Mid-Day Market Update: Crude Oil Up Over 2%; AZZ Shares Drop Following Q2 Results", "Mid-Morning Market Update: Markets Open Higher; Constellation Brands Tops Q2 Views", "Catalyst Pharma (CPRX): What???s in Store in Q4 Earnings?", "Catalyst Firdapse Gets Orphan Status for Myasthenia Gravis", "Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Up 6.3%", "Catalyst (CPRX) Reports Narrower-than-Expected Q2 Loss", "Catalyst (CPRX) Q2 Earnings: Can the Stock Pull a Surprise?", "Wednesday 7/13 Insider Buying Report: CPRX, GOOD", "Forget Valeant, Invest in These Attractive Drug Stocks Instead", "Catalyst Pharmaceuticals (CPRX) Jumps: Stock Rises 6.6%", "Mid-Afternoon Market Update: Dow Gains 125 Points; Net 1 Shares Spike Higher", "Catalyst Firdapse Gets Orphan Status for Myasthenia Gravis", "Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Up 6.3%", "Drug Stocks Reporting on May 10: XON, ARIA, CPRX & More", "What's in the Cards for Catalyst (CPRX) in Q1 Earnings?", "The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead", "Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regulatory News", "Health Care Sector Update for 06/13/2016: JNJ, PFE, ABT, MRK, AMGN, EBIO, CPRX", "Health Care Sector Update for 04/26/2016: EYEG,SMMT,CPRX", "Health Care Sector Update for 04/26/2016: NVIV,SMMT,CPRX", "Why Is Catyalyst Pharma (CPRX) Stock Crashing Today?", "Catalyst (CPRX) Posts In-Line Q4 Loss, FDA Meeting in Focus", "After-Hours Earnings Report for March 15, 2016 : ORCL, AVID, LXFR, VEC, EVRI, XONE, REI, CALL, GAIA, CHMI, CPRX, CRMD", "What's in Store for Catalyst (CPRX) this Earnings Season?", "The Zacks Analyst Blog Highlights: Catalyst Pharma, PTC Therapeutics, Radius Health, Amgen and Celgene", "Tuesday Sector Laggards: Biotechnology, Drugs", "Health Care Sector Update for 04/26/2016: EYEG,SMMT,CPRX", "Health Care Sector Update for 02/17/2016: CERN,OCUL,CPRX", "Mid-Day Market Update: Crude Oil Surges 5%; Fossil Group Shares Rise On Strong Results", "Health Care Sector Update for 02/17/2016: FLXN,OCUL,CPRX", "Mid-Afternoon Market Update: Dow Gains Over 250 Points; Catalyst Pharmaceuticals Shares Slide", "Catalyst (CPRX) Initiates Study on Firdapse for MuSK-MG", "Health Care Sector Update for 02/08/2016: SRPT, CPRX", "Biotech Stock Roundup: PTCT Plunges on \"RTF\" from FDA, Radius Shoots Up on Amgen Data", "Catalyst Pharmaceuticals Reveals Data on Neurological Drug", "Is Catalyst Pharmaceuticals (CPRX) Stock a Solid Choice Right Now?", "ArQule's Drug Gets Orphan Drug Status for Proteus Syndrome", "Catalyst Pharmaceuticals' Q3 Loss Narrower than Expected", "Catalyst Pharmaceutical (CPRX): A Peek into Q3 Earnings", "Catalyst Starts Congenital Myasthenic Syndromes Study", "Health Care Sector Update for 10/06/2015: CPRX, INFI, FATE", "Why Shares of Catalyst Pharmaceuticals Soared Today", "How Catalyst Pharmaceuticals (CPRX) Stock Stands Out in a Strong Industry", "Catalyst (CPRX) to Develop Generic Version of Sanofi's Sabril", "Catalyst Pharmaceuticals' Loss Wider Y/Y, Firdapse in Focus - Analyst Blog", "Will Catalyst Pharmaceutical (CPRX) Top in Q2 Earnings? - Analyst Blog", "Catalyst Pharmaceuticals Reports Tourette's Disorder Data - Analyst Blog", "Mid-Morning Market Update: Markets Open Lower; Lennar Beats Q2 Estimates", "Catalyst Pharmaceutical's Q1 Loss Narrower than Expected - Analyst Blog", "Catalyst Pharmaceuticals Insider Picks Up Shares of Company", "Why Catalyst Pharmaceutical Partners, Inc. Shares Are Being Decimated", "What's in Store for Juno Therapeutics this Earnings Season? - Analyst Blog", "Should You Buy Catalyst Pharmaceutical (CPRX) Ahead of Earnings? - Tale of the Tape", "Will Inovio (INO) Disappoint This Earnings Season Again? - Analyst Blog", "Will BioDelivery Sciences (BDSI) Impress this Earnings? - Analyst Blog", "What Awaits Synta Pharmaceuticals (SNTA) this Earnings? - Analyst Blog", "Will Repros (RPRX) Miss Estimates This Earnings Season? - Analyst Blog", "Can Catalyst Pharmaceutical Surprise this Earnings Season? - Analyst Blog", "Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3? - Analyst Blog", "5 Red-Hot Biotech Stocks to Buy", "Wednesday 10/8 Insider Buying Report: CPRX", "Sector Update: Slim Losses for Health Care Stocks; Catalyst Pharma Lights Up After Positive Data for Prospective Auto-Immune Treatment", "Sector Update: Health Care", "Catalyst Pharmaceutical (CPRX) Jumps: Stock Up 9% - Tale of the Tape", "Friday 1/23 Insider Buying Report: CPRX, MEIP", "Sector Update: Health Care", "Friday 6/6 Insider Buying Report: LLNW, CPRX", "Catalyst Pharmaceutical Partners Inc. (CPRX) Jumps: Stock Up 8.6% - Tale of the Tape", "Good News for Catalyst Pharma - Analyst Blog", "Catalyst Pharmaceutical Partners (CPRX) in Focus: Stock Moves 6.2% Higher - Tale of the Tape", "Narrower-than-Expected Loss at Catalyst Pharma - Analyst Blog", "Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets", "Sector Update: Health-Care Shares Higher Pre-Market", "US Stocks Seen Higher on Expected Yellen Support; Economic Data, Fed Minutes in Focus", "US Stocks Seen Extending Gains on Fed Support", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Catalyst Pharmaceutical Partners, Inc. Enters Oversold Territory - Tale of the Tape", "Healthcare Stocks Adding to Early Gains; Catalyst Pharma Surging Following Insider Buying", "Sector Update: Healthcare", "Good News for Catalyst Pharma's Pipeline - Analyst Blog", "Sector Update: Healthcare", "FDA Designation for CPRX's Firdapse - Analyst Blog", "Stocks Drop Amid Likely Syria Intervention And Domestic Debt Ceiling Fight", "US Futures Fall as Prospects for Syria Intervention Increase", "FDA Accepts Merck BLA - Analyst Blog", "Merck KGaA Posts Higher Y/Y Earnings - Analyst Blog", "Dr. Reddy's Earnings Increase Y/Y - Analyst Blog", "Forest-Trevena Ink Deal - Analyst Blog", "Catalyst Pharma Raises Funds - Analyst Blog", "Salix Beats on Earnings - Analyst Blog", "Narrower-than-Expected Loss at Supernus - Analyst Blog", "Glaxo/THRX's Breo Ellipta Gets FDA Nod - Analyst Blog", "Wider-Than-Expected Loss at Anacor - Analyst Blog", "Pacira Reports Wider Loss - Analyst Blog", "Wider-than-Expected Loss at Avanir - Analyst Blog", "Ariad Posts Wider Y/Y Loss - Analyst Blog", "Jazz Pharma Posts Higher Y/Y Earnings - Analyst Blog", "Salix Beats on Earnings - Analyst Blog", "Narrower-than-Expected Loss at Supernus - Analyst Blog", "Teva Beats on Earnings, Revenues - Analyst Blog", "Actavis Beats on Earnings, Raises View - Analyst Blog", "Earnings and Sales Rise at Novo Nordisk - Analyst Blog", "Glaxo's Trametinib Delayed - Analyst Blog", "Positive CHMP Opinion for Avanir - Analyst Blog", "Positive Data on Forest Combo Drug - Analyst Blog", "Glaxo-Impax End Rytary Deal - Analyst Blog", "Wider Loss at Auxilium, Acquires Actient - Analyst Blog", "Earnings Miss at Glaxo - Analyst Blog", "UCB Sales Drop in 1Q - Analyst Blog", "Lilly Earnings Better Than Expected - Analyst Blog", "AMAG Narrows Loss; Maintains View - Analyst Blog", "Forest Labs' Earnings Decline - Analyst Blog", "Novo Nordisk and EMIS Modify Deal - Analyst Blog", "PCYC Completes RESONATE Enrollment - Analyst Blog", "Positive Results on GlycoMimetics/Pfizer Drug - Analyst Blog", "Positive Data on Forest Candidate - Analyst Blog", "Pharmacyclics Earns 4th Milestone - Analyst Blog", "Zacks #1 Rank Additions for Thursday - Tale of the Tape", "Zacks #1 Rank Additions for Wednesday - Tale of the Tape", "Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD", "Eli Lilly in Alzheimer's Deal - Analyst Blog", "9 Biotech Penny Stocks to Buy", "9 Biotech Penny Stocks to Buy", "Catalyst Pharmaceutical: Fast Track to Big Rewards", "Weekly CFO Buys Highlight: EMC, DVOX, NANX, CPRX, CCRN"], "Elapsed Time": ["MAY 13, 2020", "MAY 12, 2020", "APR 29, 2020", "APR 29, 2020", "APR 5, 2020", "APR 2, 2020", "MAR 22, 2020", "MAR 18, 2020", "MAY 13, 2020", "MAR 8, 2020", "JAN 22, 2020", "JAN 6, 2020", "NOV 14, 2019", "NOV 13, 2019", "NOV 13, 2019", "NOV 8, 2019", "MAR 17, 2020", "OCT 8, 2019", "OCT 4, 2019", "OCT 3, 2019", "SEP 24, 2019", "SEP 23, 2019", "SEP 16, 2019", "SEP 13, 2019", "OCT 31, 2019", "SEP 12, 2019", "SEP 12, 2019", "SEP 12, 2019", "AUG 9, 2019", "AUG 8, 2019", "AUG 1, 2019", "JUL 31, 2019", "SEP 13, 2019", "MAY 13, 2019", "MAY 13, 2019", "MAY 13, 2019", "MAY 10, 2019", "MAY 7, 2019", "MAY 7, 2019", "MAY 7, 2019", "MAY 16, 2019", "APR 25, 2019", "APR 4, 2019", "MAR 31, 2019", "MAR 25, 2019", "MAR 19, 2019", "MAR 19, 2019", "MAY 7, 2019", "MAY 7, 2019", "FEB 28, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 21, 2019", "FEB 4, 2019", "MAR 19, 2019", "MAR 18, 2019", "FEB 28, 2019", "FEB 28, 2019", "NOV 29, 2018", "NOV 28, 2018", "NOV 28, 2018", "FEB 4, 2019", "NOV 9, 2018", "OCT 23, 2018", "SEP 27, 2018", "SEP 6, 2018", "AUG 8, 2018", "AUG 1, 2018", "MAY 31, 2018", "NOV 28, 2018", "MAY 2, 2018", "APR 20, 2018", "APR 13, 2018", "APR 5, 2018", "MAR 29, 2018", "MAR 15, 2018", "MAR 5, 2018", "MAY 10, 2018", "DEC 28, 2017", "DEC 2, 2017", "NOV 28, 2017", "NOV 22, 2017", "NOV 9, 2017", "NOV 6, 2017", "SEP 18, 2017", "FEB 14, 2018", "AUG 15, 2017", "AUG 10, 2017", "AUG 7, 2017", "JUL 13, 2017", "JUL 12, 2017", "JUN 28, 2017", "JUN 20, 2017", "SEP 7, 2017", "AUG 15, 2017", "AUG 10, 2017", "AUG 7, 2017", "MAY 2, 2017", "APR 19, 2017", "MAR 28, 2017", "MAR 23, 2017", "JUN 14, 2017", "MAR 15, 2017", "MAR 15, 2017", "MAR 15, 2017", "MAR 15, 2017", "MAR 15, 2017", "MAR 15, 2017", "MAR 14, 2017", "MAR 16, 2017", "NOV 14, 2016", "NOV 10, 2016", "NOV 7, 2016", "OCT 31, 2016", "OCT 5, 2016", "OCT 5, 2016", "OCT 5, 2016", "MAR 7, 2017", "SEP 6, 2016", "AUG 18, 2016", "AUG 10, 2016", "AUG 3, 2016", "JUL 13, 2016", "JUN 28, 2016", "JUN 14, 2016", "OCT 5, 2016", "SEP 6, 2016", "AUG 18, 2016", "MAY 9, 2016", "MAY 6, 2016", "APR 28, 2016", "APR 27, 2016", "JUN 13, 2016", "APR 26, 2016", "APR 26, 2016", "APR 26, 2016", "MAR 16, 2016", "MAR 15, 2016", "MAR 14, 2016", "FEB 26, 2016", "APR 26, 2016", "FEB 18, 2016", "FEB 17, 2016", "FEB 17, 2016", "FEB 17, 2016", "FEB 17, 2016", "FEB 9, 2016", "FEB 8, 2016", "FEB 25, 2016", "DEC 17, 2015", "NOV 18, 2015", "NOV 18, 2015", "NOV 10, 2015", "NOV 6, 2015", "OCT 7, 2015", "OCT 6, 2015", "DEC 17, 2015", "SEP 14, 2015", "SEP 10, 2015", "AUG 11, 2015", "AUG 7, 2015", "JUN 25, 2015", "JUN 24, 2015", "MAY 12, 2015", "OCT 5, 2015", "APR 24, 2015", "MAR 16, 2015", "MAR 16, 2015", "MAR 13, 2015", "MAR 13, 2015", "MAR 11, 2015", "MAR 11, 2015", "MAY 8, 2015", "NOV 12, 2014", "OCT 28, 2014", "OCT 8, 2014", "SEP 30, 2014", "SEP 30, 2014", "SEP 5, 2014", "JAN 23, 2015", "AUG 14, 2014", "JUN 6, 2014", "APR 4, 2014", "MAR 26, 2014", "MAR 21, 2014", "MAR 20, 2014", "JAN 8, 2014", "AUG 14, 2014", "NOV 18, 2013", "NOV 18, 2013", "NOV 7, 2013", "OCT 22, 2013", "OCT 22, 2013", "OCT 22, 2013", "OCT 16, 2013", "JAN 8, 2014", "AUG 28, 2013", "AUG 27, 2013", "AUG 27, 2013", "MAY 15, 2013", "MAY 15, 2013", "MAY 15, 2013", "MAY 14, 2013", "SEP 11, 2013", "MAY 14, 2013", "MAY 14, 2013", "MAY 13, 2013", "MAY 13, 2013", "MAY 10, 2013", "MAY 9, 2013", "MAY 8, 2013", "MAY 14, 2013", "MAY 14, 2013", "MAY 14, 2013", "MAY 6, 2013", "MAY 2, 2013", "MAY 2, 2013", "MAY 2, 2013", "MAY 1, 2013", "MAY 7, 2013", "APR 30, 2013", "APR 30, 2013", "APR 25, 2013", "APR 25, 2013", "APR 24, 2013", "APR 24, 2013", "APR 23, 2013", "MAY 1, 2013", "APR 19, 2013", "APR 18, 2013", "APR 18, 2013", "APR 15, 2013", "APR 11, 2013", "NOV 7, 2012", "JUL 9, 2012", "APR 22, 2013", "AUG 30, 2010", "AUG 30, 2010", "APR 12, 2010", "JUN 4, 2012"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-5-13-2020-2020-05-13", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q1-2020-earnings-call-transcript-2020-05-13", "https://www.nasdaq.com/articles/healthcare-pro-steven-boyd-is-gobbling-up-these-3-stocks-2020-04-29", "https://www.nasdaq.com/articles/is-catalyst-pharmaceuticals-a-buy-2020-04-29", "https://www.nasdaq.com/articles/30-top-stocks-and-funds-to-beat-the-covid-19-bear-market-2020-04-05", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-4-2-2020-2020-04-02", "https://www.nasdaq.com/articles/5-absurdly-cheap-biotech-stocks-that-could-make-you-filthy-rich-2020-03-22", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-3-18-2020-2020-03-18", "https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-5-13-2020-2020-05-13", "https://www.nasdaq.com/articles/these-14-stocks-are-stupid-cheap-2020-03-08", "https://www.nasdaq.com/articles/can-catalyst-pharmaceuticals-stock-rebound-in-2020-2020-01-22", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-jumped-today-2020-01-06", "https://www.nasdaq.com/articles/is-catalyst-pharmaceuticals-stock-safe-to-own-2019-11-14", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q3-2019-earnings-call-transcript-2019-11-13", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-is-falling-today-2019-11-13", "https://www.nasdaq.com/articles/3-strong-buy-stocks-to-buy-on-weakness-2019-11-08", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q4-2019-earnings-call-transcript-2020-03-17", "https://www.nasdaq.com/articles/catalyst-pharma%3A-are-the-risks-worth-the-potential-rewards-2019-10-08", "https://www.nasdaq.com/articles/friday-10-4-insider-buying-report%3A-wms-cprx-2019-10-04", "https://www.nasdaq.com/articles/3-top-small-cap-stocks-to-buy-in-october-2019-10-03", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals%3A-nothing-has-changed-2019-09-24", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-is-tumbling-today-2019-09-23", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-september-2019-09-16", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-13-2019%3A-rttr-fcsc-cprx-jnj-pfe-mrk-abt-amgn-2019-09-13", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals%3A-buy-the-dip-2019-10-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-12-2019%3A-vxrtpdliacbcprx-2019-09-12", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-12-2019%3A-acbpdlicprx-2019-09-12", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-is-sinking-today-2019-09-12", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q2-2019-earnings-call-transcript-2019-08-09", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-broke-down-today-2019-08-08", "https://www.nasdaq.com/articles/2-small-cap-stocks-that-could-make-you-rich-2019-08-01", "https://www.nasdaq.com/articles/2-top-stocks-to-buy-in-august-2019-07-31", "https://www.nasdaq.com/articles/5-top-losers-in-healthcare-sector-toca-advm-cprx...-2019-09-13", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-posts-strong-q1-sales-firdapse-2019-05-13", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-briefly-spiked-today-2019-05-13", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q1-2019-earnings-call-transcript-2019-05-13", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-jumping-today-2019-05-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-07-2019%3A-pinccprxhsicregnsny-2019-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-07-2019%3A-cprxhsicregnsny-2019-05-07", "https://www.nasdaq.com/articles/mid-day-market-update%3A-nautilus-falls-downbeat-q1-results-cohu-shares-surge-2019-05-07", "https://www.nasdaq.com/articles/are-these-2-beaten-down-biotech-stocks-worth-risk-2019-05-16", "https://www.nasdaq.com/articles/7-top-gainers-healthcare-sector-tlsa-swav-cprx...-2019-04-25", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-inc-soared-march-2019-04-04", "https://www.nasdaq.com/articles/3-top-biotech-stocks-buy-right-now-2019-03-31", "https://www.nasdaq.com/articles/2-high-growth-stocks-id-buy-right-now-2019-03-25", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-popping-today-2019-03-19", "https://www.nasdaq.com/articles/catalyst-cprx-reports-wider-q4-loss-focuses-on-firdapse-2019-03-19", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-getting-crushed-today-2019-05-07", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-07-2019%3A-cprx-gwph-mnk-jnj-pfe-abt-mrk-amgn-2019-05-07", "https://www.nasdaq.com/articles/us-senator-sanders-urges-fda-allow-older-versions-375000-drug-2019-02-28", "https://www.nasdaq.com/articles/catalyst-defends-375000-drug-price-after-bernie-sanders-rebuke-2019-02-21", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-defends-375000-drug-price-after-bernie-sanders-rebuke-2019-02-21", "https://www.nasdaq.com/articles/catalyst-defends-drug-price-after-bernie-sanders-rebuke-2019-02-21", "https://www.nasdaq.com/articles/us-senator-sanders-asks-why-drug-once-free-now-costs-375k-2019-02-04", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-inc-cprx-q4-2018-earnings-conference-call-transcript-2019-03-19", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-18-2019-hqy-synh-akba-xela-taco-cprx-chmi-feng-mcf-icad", "https://www.nasdaq.com/articles/us-senator-sanders-urges-fda-allow-older-versions-375k-drug-2019-02-28", "https://www.nasdaq.com/articles/us-senator-sanders-urges-fda-allow-older-versions-375000-drug-2019-02-28", "https://www.nasdaq.com/articles/why-catalyst-pharmaceuticals-stock-sinking-today-2018-11-29", "https://www.nasdaq.com/articles/health-care-sector-update-11282018-ipcicprxgwph-2018-11-28", "https://www.nasdaq.com/articles/health-care-sector-update-11282018-aqbipcicprxgwph-2018-11-28", "https://www.nasdaq.com/articles/us-senator-sanders-ask-why-drug-once-free-now-costs-375k-2019-02-04", "https://www.nasdaq.com/articles/catalyst-cprx-reports-q3-loss-as-expected-pipeline-update-2018-11-09", "https://www.nasdaq.com/articles/4-strong-buy-biotech-stocks-upcoming-fda-decisions-2018-10-23", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-catches-eye%3A-stock-jumps-6.3-2018-09-27", "https://www.nasdaq.com/articles/catalyst-cprx-up-16-since-last-earnings-report%3A-can-it-continue-2018-09-06", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q2-2018-08-08", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2018-08-01", "https://www.nasdaq.com/articles/catalysts-fridapse-gets-priority-review-by-fda-shares-up-2018-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-11282018-thcipcicprxgwph-2018-11-28", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2018-05-02", "https://www.nasdaq.com/articles/catalyst-enrolls-first-patient-in-phase-iii-firdapse-study-2018-04-20", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-down-7.4-since-earnings-report%3A-can-it-rebound-2018-04-13", "https://www.nasdaq.com/articles/catalyst-cprx-up-on-new-drug-application-for-firdapse-2018-04-05", "https://www.nasdaq.com/articles/health-care-sector-update-03292018-cprxcgenbiocpsdvhrtx-2018-03-29", "https://www.nasdaq.com/articles/catalyst-cprx-posts-in-line-q4-loss-pipeline-in-progress-2018-03-15", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2018-03-05", "https://www.nasdaq.com/articles/catalyst-cprx-posts-in-line-q1-loss-pipeline-progresses-2018-05-10", "https://www.nasdaq.com/articles/what-drives-catalyst-pharmaceuticals-above-250-this-year-2017-12-28", "https://www.nasdaq.com/articles/3-drug-stocks-soared-week-are-they-buys-2017-12-02", "https://www.nasdaq.com/articles/catalyst-cprx-reports-positive-phase-iii-data-on-firdapse-2017-11-28", "https://www.nasdaq.com/articles/catalyst-initiates-phase-ii-study-for-pipeline-drug-firdapse-2017-11-22", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q3-2017-11-09", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2017-11-06", "https://www.nasdaq.com/articles/catalyst-cprx-focused-on-two-lead-pipeline-candidates-2017-09-18", "https://www.nasdaq.com/articles/catalyst-gets-positive-fda-advise-on-firdapse-nda-refiling-2018-02-14", "https://www.nasdaq.com/articles/catalyst-cprx-focused-on-development-of-pipeline-candidates-2017-08-15", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q2-2017-08-10", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2017-08-07", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-higher-delta-air-lines-profit-misses-expectations", "https://www.nasdaq.com/articles/catalyst-cprx-shows-strength%3A-stock-adds-9.6-in-session-2017-07-12", "https://www.nasdaq.com/articles/why-is-catalyst-pharmaceuticals-stock-up-160-this-year-2017-06-28", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-lennar-tops-q2-expectations-2017-06-20", "https://www.nasdaq.com/articles/thursday-97-insider-buying-report-titn-cprx-2017-09-07", "https://www.nasdaq.com/articles/catalyst-cprx-focused-on-development-of-pipeline-candidates-2017-08-15", "https://www.nasdaq.com/articles/catalyst-cprx-posts-narrower-than-expected-loss-in-q2-2017-08-10", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2017-08-07", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-stock-in-q1-earnings-2017-05-02", "https://www.nasdaq.com/articles/catalyst-cprx-up-16.6-since-earnings-report%3A-can-it-continue-2017-04-19", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-jumps%3A-stock-gains-18.2-2017-03-28", "https://www.nasdaq.com/articles/catalyst-pharma-cprx-focused-on-u.s.-approval-for-firdapse-2017-03-23", "https://www.nasdaq.com/articles/why-is-catalyst-pharmaceuticals-cprx-up-25.5-since-the-last-earnings-report-2017-06-14", "https://www.nasdaq.com/articles/midday-update-countdown-fomc-stocks-trade-higher-uptick-oil-banking-shares-2017-03-15", "https://www.nasdaq.com/articles/mid-day-market-update-ftd-companies-drops-after-q4-results-cesca-therapeutics-shares-surge", "https://www.nasdaq.com/articles/close-update-stocks-rally-fed-rate-hike-tempered-confidence-robustness-economy-2017-03-15", "https://www.nasdaq.com/articles/health-care-sector-update-03152017-vrxcprxcxrx-2017-03-15", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-over-2-ftd-companies-shares-plunge-2017-03-15", "https://www.nasdaq.com/articles/health-care-sector-update-03152017-koolcprxcxrx-2017-03-15", "https://www.nasdaq.com/articles/health-care-sector-update-03142017-bioc-2017-03-14", "https://www.nasdaq.com/articles/catalyst-cprx-reports-narrower-than-expected-loss-in-q4-2017-03-16", "https://www.nasdaq.com/articles/alexion-alxn-offers-long-term-phase-iii-data-on-kanuma-2016-11-14", "https://www.nasdaq.com/articles/catalyst-cprx-reports-narrower-than-expected-loss-in-q3-2016-11-10", "https://www.nasdaq.com/articles/catalyst-pharma-cprx-q3-earnings%3A-will-stock-surprise-2016-11-07", "https://www.nasdaq.com/articles/health-care-sector-update-10312016-cprx-tmh-zbh-bx-2016-10-31", "https://www.nasdaq.com/articles/midday-update-oil-fuels-triple-digit-gain-dow-2016-10-05", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-over-2-azz-shares-drop-following-q2-results-2016-10-05", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-constellation-brands-tops-q2-views-2016-10", "https://www.nasdaq.com/articles/catalyst-pharma-cprx%3A-whats-in-store-in-q4-earnings-2017-03-07", "https://www.nasdaq.com/articles/catalyst-firdapse-gets-orphan-status-for-myasthenia-gravis-2016-09-06", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-looks-good%3A-stock-up-6.3-2016-08-18", "https://www.nasdaq.com/articles/catalyst-cprx-reports-narrower-than-expected-q2-loss-2016-08-10", "https://www.nasdaq.com/articles/catalyst-cprx-q2-earnings%3A-can-the-stock-pull-a-surprise-2016-08-03", "https://www.nasdaq.com/articles/wednesday-713-insider-buying-report-cprx-good-2016-07-13", "https://www.nasdaq.com/articles/forget-valeant-invest-in-these-attractive-drug-stocks-instead-2016-06-28", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-jumps%3A-stock-rises-6.6-2016-06-14", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-gains-125-points-net-1-shares-spike-higher-2016-10-05", "https://www.nasdaq.com/articles/catalyst-firdapse-gets-orphan-status-for-myasthenia-gravis-2016-09-06", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-cprx-looks-good%3A-stock-up-6.3-2016-08-18", "https://www.nasdaq.com/articles/drug-stocks-reporting-on-may-10%3A-xon-aria-cprx-more-2016-05-09", "https://www.nasdaq.com/articles/whats-in-the-cards-for-catalyst-cprx-in-q1-earnings-2016-05-06", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-biogen-sarepta-catalyst-pharmaceuticals-abbvie-and", "https://www.nasdaq.com/articles/biotech-stock-roundup-biogen-tops-q1-earnings-sarepta-catalyst-plunge-regulatory-news-2016", "https://www.nasdaq.com/articles/health-care-sector-update-06132016-jnj-pfe-abt-mrk-amgn-ebio-cprx-2016-06-13", "https://www.nasdaq.com/articles/health-care-sector-update-04262016-eyegsmmtcprx-2016-04-26", "https://www.nasdaq.com/articles/health-care-sector-update-04262016-nvivsmmtcprx-2016-04-26", "https://www.nasdaq.com/articles/why-catyalyst-pharma-cprx-stock-crashing-today-2016-04-26", "https://www.nasdaq.com/articles/catalyst-cprx-posts-in-line-q4-loss-fda-meeting-in-focus-2016-03-16", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-15-2016-orcl-avid-lxfr-vec-evri-xone-rei-call-gaia-chmi", "https://www.nasdaq.com/articles/whats-in-store-for-catalyst-cprx-this-earnings-season-2016-03-14", "https://www.nasdaq.com/articles/the-zacks-analyst-blog-highlights%3A-catalyst-pharma-ptc-therapeutics-radius-health-amgen", "https://www.nasdaq.com/articles/tuesday-sector-laggards-biotechnology-drugs-2016-04-26", "https://www.nasdaq.com/articles/catalyst-cprx-down-on-fdas-refusal-to-file-firdapse-nda-2016-02-18", "https://www.nasdaq.com/articles/health-care-sector-update-02172016-cernoculcprx-2016-02-17", "https://www.nasdaq.com/articles/mid-day-market-update-crude-oil-surges-5-fossil-group-shares-rise-strong-results-2016-02", "https://www.nasdaq.com/articles/health-care-sector-update-02172016-flxnoculcprx-2016-02-17", "https://www.nasdaq.com/articles/mid-afternoon-market-update-dow-gains-over-250-points-catalyst-pharmaceuticals-shares", "https://www.nasdaq.com/articles/catalyst-cprx-initiates-study-on-firdapse-for-musk-mg-2016-02-09", "https://www.nasdaq.com/articles/health-care-sector-update-02082016-srpt-cprx-2016-02-08", "https://www.nasdaq.com/articles/biotech-stock-roundup-ptct-plunges-rtf-fda-radius-shoots-amgen-data-2016-02-25", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-reveals-data-on-neurological-drug-2015-12-17", "https://www.nasdaq.com/articles/is-catalyst-pharmaceuticals-cprx-stock-a-solid-choice-right-now-2015-11-18", "https://www.nasdaq.com/articles/arqules-drug-gets-orphan-drug-status-for-proteus-syndrome-2015-11-18", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-q3-loss-narrower-than-expected-2015-11-10", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-cprx%3A-a-peek-into-q3-earnings-2015-11-06", "https://www.nasdaq.com/articles/catalyst-starts-congenital-myasthenic-syndromes-study-2015-10-07", "https://www.nasdaq.com/articles/health-care-sector-update-10062015-cprx-infi-fate-2015-10-06", "https://www.nasdaq.com/articles/why-shares-catalyst-pharmaceuticals-soared-today-2015-12-17", "https://www.nasdaq.com/articles/how-catalyst-pharmaceuticals-cprx-stock-stands-out-in-a-strong-industry-2015-09-14", "https://www.nasdaq.com/articles/catalyst-cprx-to-develop-generic-version-of-sanofis-sabril-2015-09-10", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-loss-wider-y-y-firdapse-in-focus-analyst-blog-2015-08-11", "https://www.nasdaq.com/articles/will-catalyst-pharmaceutical-cprx-top-in-q2-earnings-analyst-blog-2015-08-07", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-reports-tourettes-disorder-data-analyst-blog-2015-06-25", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-lennar-beats-q2-estimates-2015-06-24", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-q1-loss-narrower-than-expected-analyst-blog-2015-05-12", "https://www.nasdaq.com/articles/catalyst-pharmaceuticals-insider-picks-shares-company-2015-10-05", "https://www.nasdaq.com/articles/why-catalyst-pharmaceutical-partners-inc-shares-are-being-decimated-2015-04-24", "https://www.nasdaq.com/articles/whats-in-store-for-juno-therapeutics-this-earnings-season-analyst-blog-2015-03-16", "https://www.nasdaq.com/articles/should-you-buy-catalyst-pharmaceutical-cprx-ahead-of-earnings-tale-of-the-tape-2015-03-16", "https://www.nasdaq.com/articles/will-inovio-ino-disappoint-this-earnings-season-again-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/will-biodelivery-sciences-bdsi-impress-this-earnings-analyst-blog-2015-03-13", "https://www.nasdaq.com/articles/what-awaits-synta-pharmaceuticals-snta-this-earnings-analyst-blog-2015-03-11", "https://www.nasdaq.com/articles/will-repros-rprx-miss-estimates-this-earnings-season-analyst-blog-2015-03-11", "https://www.nasdaq.com/articles/can-catalyst-pharmaceutical-surprise-this-earnings-season-analyst-blog-2015-05-08", "https://www.nasdaq.com/articles/will-catalyst-pharmaceuticals-cprx-loss-narrow-in-q3-analyst-blog-2014-11-12", "https://www.nasdaq.com/articles/5-red-hot-biotech-stocks-buy-2014-10-28", "https://www.nasdaq.com/articles/wednesday-108-insider-buying-report-cprx-2014-10-08", "https://www.nasdaq.com/articles/sector-update-slim-losses-health-care-stocks-catalyst-pharma-lights-after-positive-data", "https://www.nasdaq.com/articles/sector-update-health-care-2014-09-30-0", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-cprx-jumps%3A-stock-up-9-tale-of-the-tape-2014-09-05", "https://www.nasdaq.com/articles/friday-123-insider-buying-report-cprx-meip-2015-01-23", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-14-1", "https://www.nasdaq.com/articles/friday-66-insider-buying-report-llnw-cprx-2014-06-06", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-partners-inc.-cprx-jumps%3A-stock-up-8.6-tale-of-the-tape-2014-04-04", "https://www.nasdaq.com/articles/good-news-for-catalyst-pharma-analyst-blog-2014-03-26", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-partners-cprx-in-focus%3A-stock-moves-6.2-higher-tale-of-the-tape", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-catalyst-pharma-analyst-blog-2014-03-20", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-catalyst-pharmaceutical-partners-rises-14", "https://www.nasdaq.com/articles/sector-update-health-care-shares-higher-pre-market-2014-08-14", "https://www.nasdaq.com/articles/us-stocks-seen-higher-expected-yellen-support-economic-data-fed-minutes-focus-2013-11-18", "https://www.nasdaq.com/articles/us-stocks-seen-extending-gains-fed-support-2013-11-18", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2013-11-07", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-partners-inc.-enters-oversold-territory-tale-of-the-tape-2013-10", "https://www.nasdaq.com/articles/healthcare-stocks-adding-early-gains-catalyst-pharma-surging-following-insider-buying-2013", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-22-1", "https://www.nasdaq.com/articles/good-news-for-catalyst-pharmas-pipeline-analyst-blog-2013-10-16", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-01-08-1", "https://www.nasdaq.com/articles/fda-designation-for-cprxs-firdapse-analyst-blog-2013-08-28", "https://www.nasdaq.com/articles/stocks-drop-amid-likely-syria-intervention-and-domestic-debt-ceiling-fight-2013-08-27", "https://www.nasdaq.com/articles/us-futures-fall-prospects-syria-intervention-increase-2013-08-27", "https://www.nasdaq.com/articles/fda-accepts-merck-bla-analyst-blog-2013-05-15", "https://www.nasdaq.com/articles/merck-kgaa-posts-higher-y-y-earnings-analyst-blog-2013-05-15", "https://www.nasdaq.com/articles/dr.-reddys-earnings-increase-y-y-analyst-blog-2013-05-15", "https://www.nasdaq.com/articles/forest-trevena-ink-deal-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/catalyst-pharma-raises-funds-analyst-blog-2013-09-11", "https://www.nasdaq.com/articles/salix-beats-on-earnings-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-supernus-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/glaxo-thrxs-breo-ellipta-gets-fda-nod-analyst-blog-2013-05-13", "https://www.nasdaq.com/articles/wider-than-expected-loss-at-anacor-analyst-blog-2013-05-13", "https://www.nasdaq.com/articles/pacira-reports-wider-loss-analyst-blog-2013-05-10", "https://www.nasdaq.com/articles/wider-than-expected-loss-at-avanir-analyst-blog-2013-05-09", "https://www.nasdaq.com/articles/ariad-posts-wider-y-y-loss-analyst-blog-2013-05-08", "https://www.nasdaq.com/articles/jazz-pharma-posts-higher-y-y-earnings-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/salix-beats-on-earnings-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/narrower-than-expected-loss-at-supernus-analyst-blog-2013-05-14", "https://www.nasdaq.com/articles/teva-beats-on-earnings-revenues-analyst-blog-2013-05-06", "https://www.nasdaq.com/articles/actavis-beats-on-earnings-raises-view-analyst-blog-2013-05-02", "https://www.nasdaq.com/articles/earnings-and-sales-rise-at-novo-nordisk-analyst-blog-2013-05-02", "https://www.nasdaq.com/articles/glaxos-trametinib-delayed-analyst-blog-2013-05-02", "https://www.nasdaq.com/articles/positive-chmp-opinion-for-avanir-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/positive-data-on-forest-combo-drug-analyst-blog-2013-05-07", "https://www.nasdaq.com/articles/glaxo-impax-end-rytary-deal-analyst-blog-2013-04-30", "https://www.nasdaq.com/articles/wider-loss-at-auxilium-acquires-actient-analyst-blog-2013-04-30", "https://www.nasdaq.com/articles/earnings-miss-at-glaxo-analyst-blog-2013-04-25", "https://www.nasdaq.com/articles/ucb-sales-drop-in-1q-analyst-blog-2013-04-25", "https://www.nasdaq.com/articles/lilly-earnings-better-than-expected-analyst-blog-2013-04-24", "https://www.nasdaq.com/articles/amag-narrows-loss-maintains-view-analyst-blog-2013-04-24", "https://www.nasdaq.com/articles/forest-labs-earnings-decline-analyst-blog-2013-04-23", "https://www.nasdaq.com/articles/novo-nordisk-and-emis-modify-deal-analyst-blog-2013-05-01", "https://www.nasdaq.com/articles/pcyc-completes-resonate-enrollment-analyst-blog-2013-04-19", "https://www.nasdaq.com/articles/positive-results-on-glycomimetics-pfizer-drug-analyst-blog-2013-04-18", "https://www.nasdaq.com/articles/positive-data-on-forest-candidate-analyst-blog-2013-04-18", "https://www.nasdaq.com/articles/pharmacyclics-earns-4th-milestone-analyst-blog-2013-04-15", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-thursday-tale-of-the-tape-2013-04-11", "https://www.nasdaq.com/articles/zacks-1-rank-additions-for-wednesday-tale-of-the-tape-2012-11-07", "https://www.nasdaq.com/articles/weekly-cfo-buys-highlight-cprx-appy-mei-mnkd-2012-07-09", "https://www.nasdaq.com/articles/eli-lilly-in-alzheimers-deal-analyst-blog-2013-04-22", "https://www.nasdaq.com/articles/9-biotech-penny-stocks-buy-2010-08-30-0", "https://www.nasdaq.com/articles/9-biotech-penny-stocks-buy-2010-08-30", "https://www.nasdaq.com/articles/catalyst-pharmaceutical-fast-track-big-rewards-2010-04-12", "https://www.nasdaq.com/articles/weekly-cfo-buys-highlight-emc-dvox-nanx-cprx-ccrn-2012-06-04"], "Content": []}